Eton Pharmaceuticals, Inc.Eton Pharmaceuticals, Inc.Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals, Inc.

No trades
See on Supercharts
Market capitalization
‪78.61 M‬USD
−0.04USD
‪−936.00 K‬USD
‪31.64 M‬USD
‪22.43 M‬
Beta (1Y)
0.65

About Eton Pharmaceuticals, Inc.

CEO
Sean E. Brynjelsen
Headquarters
Deer Park
Employees (FY)
30
Founded
2017
ISIN
US29772L1089
FIGI
BBG00H0KCMV1
Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ETON is 3.19 USD — it has increased by 4.25% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Eton Pharmaceuticals, Inc. stocks are traded under the ticker ETON.
Eton Pharmaceuticals, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
ETON stock is 5.26% volatile and has beta coefficient of 0.65. Check out the list of the most volatile stocks — is Eton Pharmaceuticals, Inc. there?
ETON earnings for the last quarter are −0.02 USD per share, whereas the estimation was −0.10 USD resulting in a 80.00% surprise. The estimated earnings for the next quarter are −0.04 USD per share. See more details about Eton Pharmaceuticals, Inc. earnings.
Eton Pharmaceuticals, Inc. revenue for the last quarter amounts to ‪7.03 M‬ USD despite the estimated figure of ‪6.26 M‬ USD. In the next quarter revenue is expected to reach ‪7.70 M‬ USD.
Yes, you can track Eton Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
ETON stock has fallen by 8.07% compared to the previous week, the month change is a 9.89% fall, over the last year Eton Pharmaceuticals, Inc. has showed a 12.36% decrease.
ETON net income for the last quarter is ‪−2.26 M‬ USD, while the quarter before that showed ‪−579.00 K‬ USD of net income which accounts for −289.64% change. Track more Eton Pharmaceuticals, Inc. financial stats to get the full picture.
Today Eton Pharmaceuticals, Inc. has the market capitalization of ‪78.61 M‬, it has decreased by 6.25% over the last week.
No, ETON doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ETON shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Eton Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
ETON reached its all-time high on Feb 9, 2021 with the price of 10.30 USD, and its all-time low was 1.95 USD and was reached on Sep 23, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 30.00 employees. See our rating of the largest employees — is Eton Pharmaceuticals, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Eton Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Eton Pharmaceuticals, Inc. stock shows the sell signal. See more of Eton Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Eton Pharmaceuticals, Inc. EBITDA is ‪−290.00 K‬ USD, and current EBITDA margin is −0.92%. See more stats in Eton Pharmaceuticals, Inc. financial statements.